Acceptability and Feasibility of MOL in Acute Inpatient Units
Is Method of Levels (MOL) Therapy an Acceptable and Feasible Psychological Intervention for People in Acute Mental Health Inpatient Services: A Case Series.
1 other identifier
interventional
14
1 country
2
Brief Summary
The current study aims to test the acceptability and feasibility of a psychological therapy called Method of Levels (MOL) as an intervention for people in acute psychiatric inpatient units who are experiencing psychosis and/or suicidality.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2022
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 8, 2022
CompletedFirst Posted
Study publicly available on registry
May 17, 2022
CompletedStudy Start
First participant enrolled
August 10, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2023
CompletedMay 15, 2023
May 1, 2023
6 months
May 8, 2022
May 12, 2023
Conditions
Outcome Measures
Primary Outcomes (7)
Proportion of approved patients recruited
We will deem the study feasible if at least 72% of approached people consent to participate
Study consent meeting, approx. 1 week after initial meeting
Proportion of recruited patients retained
We will deem the study feasible if least 62% of recruited participants are retained (i.e. receive at least one therapy session and complete the end of therapy measures and interview)
End of therapy interview
Number of participants who receiving the intervention
We will deem the study feasible if 10 participants receive at least one therapy session
End of first therapy session, approx. 2 weeks after initial meeting
Acceptability (qualitative)
Qualitative interview with participant at end of therapy analysed using Thematic Analysis
End of therapy interview
Results of Novel Client Measure (descriptive)
Qualitative self-reported perception of what was helpful about the therapeutic environment
End of therapy research meeting
Results of Outcome Rating Scale (descriptive)
Qualitative self-report measure assessing areas of life functioning known to change as a result of therapeutic intervention
End of therapy research meeting
Feasibility of adaptions required
Qualitative record of adaptions required for use of MOL in an acute inpatient setting
Final follow up meeting with final participant, 3 months after consent
Other Outcomes (5)
Psychological Outcomes Profile (descriptive)
End of therapy research meeting
Clinical Outcomes in Routine Evaluation-OM (descriptive)
End of therapy research meeting
Reorganisation of Conflict Scale (descriptive)
End of therapy research meeting
- +2 more other outcomes
Study Arms (1)
MOL therapy
EXPERIMENTALParticipants with Psychosis and/or Suicidality receiving MOL therapy
Interventions
MOL therapy aims to help people develop awareness of their personal goals so they can identify incompatibilities and find potential solutions. In MOL, the therapist uses a specific style to help people focus attention on the problem at hand, long enough to consider the issues from different perspectives, including reflection on the associated emotions. This process is usually very experiential and requires the client to be actively engaged in controlling the focus of the session and decision making.
Eligibility Criteria
You may qualify if:
- Adults over the age of 18 years
- Current service user in an acute inpatient ward in the Greater Manchester area
- Capacity to provide informed consent for participating in research
- Good command of English language
- WS1: Experiencing psychosis (this will be screened for using a clinical cut-off score on the CAPE (Mossaheb et al., 2012))
- WS2: Experiencing suicidality (this will be screened for using a cynical cut-off score on the Suicidal Behaviours Questionnaire - revised (SBQ-R) (Osman et al., 2001))
You may not qualify if:
- Problems of an organic nature or a learning disability that might affect cognitive functioning
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
GMMH Park House
Manchester, United Kingdom
GMMH: Laureate House
Manchester, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sara Tai, DClinPsy
University of Manchester
- PRINCIPAL INVESTIGATOR
Yvonne Awenat, PhD
University of Manchester
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Ms Lydia Carr, Trainee Clinical Psychologist
Study Record Dates
First Submitted
May 8, 2022
First Posted
May 17, 2022
Study Start
August 10, 2022
Primary Completion
January 30, 2023
Study Completion
February 1, 2023
Last Updated
May 15, 2023
Record last verified: 2023-05